Us2.ca vs qXR-CTR
AI Verdict
Choose Us2.ca if…
Choose Us2.ai if your cardiology department requires fully automated, comprehensive echocardiography analysis to generate detailed cardiac reports and detect a wide range of cardiac diseases. This tool is ideal for enhancing diagnostic accuracy and workflow efficiency in echo labs by providing real-time, zero-click processing of complex cardiac structural and functional parameters.
View Us2.ca →Choose qXR-CTR if…
Choose qXR-CTR if your radiology or emergency department needs a rapid, automated solution for assessing heart size and potential heart failure risk directly from chest X-ray images. This tool is best suited for initial screening and quick identification of an elevated cardiothoracic ratio, providing a focused assessment to aid in early risk stratification.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Us2.ca | qXR-CTR |
|---|---|---|
| Deployment | Vendor-neutral across GE, Philips, Siemens, Canon and handheld POCUS. | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Us2.caTool A explicitly highlights 'fully automated echocardiography analysis (zero clicks)' and 'editable annotations and visual overlays', indicating a highly streamlined and user-friendly experience that minimizes manual intervention and offers clinician control. While Tool B automates CTR measurement, its description lacks similar details regarding user interaction or explainability features.
Clinical Value
Us2.caTool A offers comprehensive, automated echocardiography analysis, including a wide range of structural and functional parameters, and AI-powered detection for multiple cardiac diseases like Cardiac Amyloidosis, Heart Failure, and Aortic Stenosis. Tool B, in contrast, provides a more focused assessment by automating only the cardiothoracic ratio measurement from chest X-rays.
Pricing & Value
TieBoth Tool A and Tool B state that pricing information is not publicly disclosed and requires direct contact for a quote. Without specific pricing details or publicly available cost-benefit analyses, it is not possible to determine which tool offers better value.
Enterprise Readiness
Us2.caBoth tools offer HIPAA compliance, BAA availability, FDA clearance, and flexible deployment options (cloud/on-premise). However, Tool A provides more explicit details on integration with various healthcare systems (ultrasound devices, PACS, CVIS, EMR) and proactively addresses common IT security and deployment questions, demonstrating a more comprehensive approach to enterprise integration.
Innovation
Us2.caTool A demonstrates higher innovation by fully automating complex echocardiography analysis with 'zero clicks', incorporating AI-powered disease detection for multiple conditions, and offering explainable AI with editable annotations. Tool B's automation of the cardiothoracic ratio from chest X-rays, while valuable, is a more singular and less complex application of AI in comparison.
Support & Docs
qXR-CTRWhile both tools provide contact information and documentation, Tool B explicitly commits to assigning a 'dedicated client success partner' to every hospital and guarantees a response time of less than 6 hours for email queries. This indicates a more structured and responsive support framework compared to the general contact and documentation resources offered by Tool A.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Us2.ca | qXR-CTR |
|---|---|---|
| Name | Us2.ca | qXR-CTR |
| Company | Eko.Ai Pte Ltd. D/B/A Us2.Ai | Qure.ai Technologies |
| Description | Us2.ai is an FDA-cleared and CE-marked AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and workflow efficiency. | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Primary Function | Fully automated echocardiography analysis (zero clicks), real-time processing and structured report generation, AI-powered disease detection (e.g., Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension). | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Us2.ca and qXR-CTR.